Research Article
Ayanos Taye and Mohammed Yuya
Abstract
Background: In Ethiopia, maternal mortality rate is 676/100,000 live births which making it one of the six countries contributing 50% of maternal death in the global. Among the cause of death, obstructed labour and its complication has significant figure. Despite this, Ethiopia has low institutional delivery and C/S rate with the recent figures of being 10% and < 2%, respectively, Objective: The objective of this study aims to assess the prevalence of Caesarean section in JUSH. Methods: Hospital based retrospective cross sectional study was carried out at Jimma University specialized hospital from March 1st - April 1st, 2014. Data was collected from records of deliveries from January 1st up to December 31st, 2013 using structured check lists from records of the operation room, labour ward registration and patient charts. The descriptive statistics and chi square were used to analyse/compute some variables by using computer. Result: The overall prevalence of C/S in the study area was 28.1%. The common indication of Caesarean section in the study area was CPD (14.1%) which was followed by Previous C/S (3.8%). Fever (6.21%) and fistula (2) were among complications raised after C/S. Based on statistical test,1000172there was significant association between prevalence of C/S and age-group of the mother’s (x2 = 24.4, p = 0.00), address of mother’s(x2 = 15, p = 0.00), ANC follow up (x2 = 22.9, p = 0.00), number of the foetus (x2 = 7.01, p = 0.03) and history of previous c/s (x2 = 8.7, p = 0.003).1000172 Conclusions and recommendations: Based on this finding it was concluded that the prevalence of C/S in JUSH was higher than the WHO recommendation. The most common indication of C/S was CPD. Caesarean section was statistically significant association with age of the mothers, address of mothers, ANC follow up, number of foetus and history of previous C/S. Based on the above findings, JUSH department of Obstetrics and Gynaecology should restrict the indication of C/S and improve trial of VBAC and instrumental vaginal deliveries.